HANK, JACQUELYN A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the Children's Cancer Group

Jami D. Frost, Jacquelyn A. Hank, Gregory H. Reaman, Sharon Frierdich, Robert C. Seeger, Jacek Gan, Peter M. Anderson, Lawrence J. Ettinger, Mitchell S. Cairo, Bruce R. Blazar, Mark D. Krailo, Katheri

Journal:

Year:

1997

Language:

english

File:

PDF, 419 KB

english, 1997

2

A Phase Ib/II trial of granulocyte-macrophage−colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases : A case of fatal central nervous system thrombosis

Kirsten M. Hotton, Masoud Khorsand, Jacquelyn A. Hank, Mark Albertini, Kyung Mann Kim, George Wilding, M. Shahriar Salamat, Marilyn Larson, Paul Sondel, Joan H. Schiller

Journal:

Year:

2000

Language:

english

File:

PDF, 187 KB

english, 2000

3

Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes. A case report and phase I trial

Peter C. Kohler, Jacquelyn A. Hank, Robert Exten, Deborah Z. Minkoff, Douglas G. Wilson, Paul M. Sondel

Journal:

Year:

1985

Language:

english

File:

PDF, 1.19 MB

english, 1985

4

the influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2

Mark R. Albertini, Jeffrey A. Sosman, Jacquelyn A. Hank, Karen H. Moore, Agnes Borchert, Kathleen Schell, Peter C. Kohler, Robin Bechhofer, Barry Storer, Paul M. Sondel

Journal:

Year:

1990

Language:

english

File:

PDF, 863 KB

english, 1990

5

A phase II trial of human recombinant lnterleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study

Madeline Bauer, Gregory H. Reaman, Jacquelyn A. Hank, Mitchell S. Cairo, Peter Anderson, Bruce R. Blazar, Sharon Frierdich, Paul M. Sondel

Journal:

Year:

1995

Language:

english

File:

PDF, 619 KB

english, 1995

6

Long-term maintenance of “cloned” human PLT cells in TCGF with LCL cells as a feeder layer

Jacquelyn A. Hank, Hiroo Inouye, Lynn A. Guy, Barbara J. Alter, Fritz H. Bach

Journal:

Journal of Cellular Biochemistry

Year:

1980

Language:

english

File:

PDF, 415 KB

english, 1980

7

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Paul M. Sondel, Jacquelyn A. Hank, Peter C. Kohler, Jeff A. Sosman, Gilda Weil-Hillman, Paul Fisch, Fritz H. Bach

Journal:

Critical Reviews in Oncology/Hematology

Year:

1989

Language:

english

File:

PDF, 1.69 MB

english, 1989

8

Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation

Stephan D. Voss, Jacquelyn A. Hank, Catherine A. Nobis, Paul Fisch, Jeff A. Sosman, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1989

Language:

english

File:

PDF, 1003 KB

english, 1989

9

Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions

Peter C. Kohler, Jacquelyn A. Hank, Deborah Z. Minkoff, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1988

Language:

english

File:

PDF, 1.09 MB

english, 1988

10

Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs

Stuart C. Helfand, Steve A. Soergel, Peter S. MacWilliams, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1994

Language:

english

File:

PDF, 1.16 MB

english, 1994

11

Addition of interleukin-2in vitroaugments detection of lymphokine-activated killer activity generatedin vivo

Jacquelyn A. Hank, Gilda Weil-Hillman, Jean E. Surfus, Jeffrey A. Sosman, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1990

Language:

english

File:

PDF, 968 KB

english, 1990

12

Analysis of T cell receptor β and γ genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients

Mark R. Albertini, Janice A. Nicklas, Bettejayne F. Chastenay, Timothy C. Hunter, Richard J. Albertini, Steven S. Clark, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1991

Language:

english

File:

PDF, 1.30 MB

english, 1991

13

BLT-esterase activity followingin vitroandin vivoactivation of human lymphocytes with interleukin-2

Adria Cannon, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Year:

1991

Language:

english

File:

PDF, 765 KB

english, 1991

14

Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein

I. Bruce Rosenzweig, Donald A. Wiebe, Jacquelyn A. Hank, John J. Albers, Janet L. Adolphson, Ernest Borden, Earl S. Shrago, Paul M. Sondel

Journal:

Year:

1990

Language:

english

File:

PDF, 592 KB

english, 1990

15

Strategies for improving antitumor activity utilizing IL-2: Preclinical models and analysis of antitumor activity of lymphocytes from patients receiving IL-2

Mark R. Albertini, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Year:

1992

Language:

english

File:

PDF, 1.12 MB

english, 1992

16

Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

Brian S. Choi, Paul M. Sondel, Jacquelyn A. Hank, Heidi Schalch, Jacek Gan, David M. King, Kari Kendra, David Mahvi, Li-Yin Lee, KyungMann Kim, Mark R. Albertini

Journal:

Cancer Immunology, Immunotherapy

Year:

2006

Language:

english

File:

PDF, 429 KB

english, 2006

17

Intratumoral immunocytokine treatment results in enhanced antitumor effects

Erik E. Johnson, Hillary D. Lum, Alexander L. Rakhmilevich, Brian E. Schmidt, Meghan Furlong, Ilia N. Buhtoiarov, Jacquelyn A. Hank, Andrew Raubitschek, David Colcher, Ralph A. Reisfeld, Stephen D. Gi

Journal:

Cancer Immunology, Immunotherapy

Year:

2008

Language:

english

File:

PDF, 401 KB

english, 2008

18

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model

Brenda L. Soto, Jacquelyn A. Hank, Tyler J. Van De Voort, Lalita Subramanian, Arthur S. Polans, Alexander L. Rakhmilevich, Richard K. Yang, Songwong Seo, KyungMann Kim, Ralph A. Reisfeld, Stephen D. G

Journal:

Cancer Immunology, Immunotherapy

Year:

2011

Language:

english

File:

PDF, 1.32 MB

english, 2011

19

Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface

Jennifer A. A. Gubbels, Brian Gadbaw, Ilia N. Buhtoiarov, Sachi Horibata, Arvinder K. Kapur, Dhara Patel, Jacquelyn A. Hank, Stephen D. Gillies, Paul M. Sondel, Manish S. Patankar, Joseph Connor

Journal:

Cancer Immunology, Immunotherapy

Year:

2011

Language:

english

File:

PDF, 735 KB

english, 2011

20

Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapy

Charles M. Nicolet, Jean M. Surfus, Jacquelyn A. Hank, P. M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1998

Language:

english

File:

PDF, 704 KB

english, 1998

21

Pharmacokinetics and stability of the ch14.18–interleukin-2 fusion protein in mice

Kari Kendra, Jacek Gan, Melody Ricci, Jean Surfus, Anisa Shaker, Michael Super, Jami D. Frost, Alexander Rakhmilevich, Jacquelyn A. Hank, Stephen D. Gillies, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

1999

Language:

english

File:

PDF, 216 KB

english, 1999

22

Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity

Bach, Fritz H., Inouye, Hiroo, Hank, Jacquelyn A., Alter, Barbara J.

Journal:

Year:

1979

File:

PDF, 359 KB

1979

23

Human Peripheral γδ T Cells Are Stimulated by Daudi Burkitt's Lymphoma and Not by Any Other Burkitt's Lymphoma Tested

Indreshpal Kaur, Jill de Jong, Kathleen Schell, Jacquelyn Hank, Paul Fisch, Paul M. Sondel

Journal:

Cellular Immunology

Year:

1994

File:

PDF, 254 KB

1994

24

Lysis of Human Tumor Cell Lines by Canine Complement plus Monoclonal Antiganglioside Antibodies or Natural Canine Xenoantibodies

Stuart C. Helfand, Jacquelyn A. Hank, Jacek Gan, Paul M. Sondel

Journal:

Cellular Immunology

Year:

1996

Language:

english

File:

PDF, 199 KB

english, 1996

25

Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines

Pamela J. Reitnauer, Lawrence R. Brown, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Cellular Immunology

Year:

1986

Language:

english

File:

PDF, 926 KB

english, 1986

26

Nonrestricted cytotoxicity mediated by interleukin 2-expanded leukocytes is inhibited by anti-LFA-1 monoclonal antibodies (MoAb) but potentiated by anti-CD3 MoAb

Benjamin P. Chen, Miroslav Malkovsky, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Cellular Immunology

Year:

1987

Language:

english

File:

PDF, 857 KB

english, 1987

27

CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules

Benjamin P. Chen, Robert DeMars, Jacquelyn A. Hank, Paul M. Sondel

Journal:

Cellular Immunology

Year:

1988

Language:

english

File:

PDF, 881 KB

english, 1988

28

Selective lysis of target cells by interleukin-2-expanded peripheral blood mononuclear leukocyte clones

Benjamin P. Chen, Jacquelyn A. Hank, Eric E. Kraus, Paul M. Sondel

Journal:

Cellular Immunology

Year:

1989

Language:

english

File:

PDF, 890 KB

english, 1989

29

The in vivo distribution of indium-111 labeled in vitro alloactivated syngeneic lymphocytes in a patient with relapsed acute myelomonocytic leukemia: Implications for adoptive chemoimmunotherapy

Paul M. Sondel, Peter C. Kohler, Jacquelyn A. Hank, Marek J. Bozdech, Lionel M. Lieberman, Richard Hong, Richard Albertini, Robert E. Exten

Journal:

Leukemia Research

Year:

1984

Language:

english

File:

PDF, 1.80 MB

english, 1984

30

Addition of systemic IL2 increases effectiveness of hu14.18-IL2 immunocytokine therapy against NXS2 murine neuroblastoma

Jeannie C. Yang, Zane Neal, Alexander Rakhmilevich, Ilia Buhtoiarov, Hillary Lum, Michael Imboden, Jacquelyn Hank, Holger Lode, Ralph Reisfeld, Stephen Gillies, Paul Sondel

Journal:

Journal of the American College of Surgeons

Year:

2004

Language:

english

File:

PDF, 54 KB

english, 2004

31

Heated lymphocytes express HLA-DR antigens despite their inability to stimulate in MLC

JACK A BREWER, JACQUELYN A HANK, THAD WENDEL, GREGORY J SCHMELING, JUDITH L BLANK, LAWRENCE W MORRISSEY, H. IAN ROBINS, PAUL M SONDEL

Journal:

Tissue Antigens

Year:

1983

Language:

english

File:

PDF, 631 KB

english, 1983

32

Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy

Brenda L. Soto, Jacquelyn A. Hank, Soesiawati R. Darjatmoko, Arthur S. Polans, Eric M. Yanke, Alexander L. Rakhmilevich, Songwon Seo, KyungMann Kim, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sond

Journal:

International Immunopharmacology

Year:

2011

Language:

english

File:

PDF, 2.18 MB

english, 2011

33

Phase II trial of hu14.18-IL2 for patients with metastatic melanoma

Mark R. Albertini, Jacquelyn A. Hank, Brian Gadbaw, Jordan Kostlevy, Jennifer Haldeman, Heidi Schalch, Jacek Gan, KyungMann Kim, Jens Eickhoff, Stephen D. Gillies, Paul M. Sondel

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 319 KB

english, 2012

34

Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): Heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells

Mandell, Randy B., Hank, Jacquelyn A., Chen, Benjamin P., Robins, H.Ian, Sondel, Paul M.

Journal:

Human Immunology

Year:

1987

Language:

english

File:

PDF, 1.17 MB

english, 1987

35

ANTIBODY-DIRECTED, EFFECTOR CELL-MEDIATED TUMOR DESTRUCTION

Sondel, Paul M., Hank, Jacquelyn A.

Journal:

Hematology/Oncology Clinics of North America

Year:

2001

Language:

english

File:

PDF, 1.14 MB

english, 2001

36

Recognition of autologous lymphoblastoid cells by cloned human T cells: Inhibition of cytotoxicity by Anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen

Hank, Jacquelyn A., Sondel, Paul M.

Journal:

Human Immunology

Year:

1984

Language:

english

File:

PDF, 576 KB

english, 1984

37

Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells

Sheridan, Rachael T. C., Hudon, Jonathan, Hank, Jacquelyn A., Sondel, Paul M., Kiessling, Laura L.

Journal:

Year:

2014

Language:

english

File:

PDF, 673 KB

english, 2014

38

Phase 1 Clinical Trial of Recombinant Interleukin-2: A Comparison of Bolus and Continuous Intravenous Infusion

Kohler, Peter C., Hank, Jacquelyn A., Moore, Karen H., Storer, Barry, Bechhofer, Robin, Hong, Richard, Sondel, Paul M.

Journal:

Cancer Investigation

Year:

1989

Language:

english

File:

PDF, 811 KB

english, 1989

39

Induction Of Lymphokine-Activated Killer (LAK) Activity in Canine Lymphocytes with Low Dose Human Recombinant InterIeukin-2 in vitro

Helfand, Stuart C., Soergel, Steve A., Modiano, Jaime F., Hank, Jacquelyn A., Sondel, Paul M.

Journal:

Cancer Biotherapy

Year:

1994

Language:

english

File:

PDF, 1.04 MB

english, 1994

40

Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom

Sosman, Jeff A., Hank, Jacquelyn A., Moore, Karen H., Borchert, Agnes, Schell, Kathleen, Kohler, Peter C., Goldstein, David, Bechhofer, Robin, Storer, Barry, Albertini, Mark R., Leung, Pearl E., Levit

Journal:

Cancer Investigation

Year:

1991

Language:

english

File:

PDF, 1.24 MB

english, 1991

41

NK Cell-based Immunotherapies in Pediatric Oncology

McDowell, Kimberly A., Hank, Jacquelyn A., DeSantes, Kenneth B., Capitini, Christian M., Otto, Mario, Sondel, Paul M.

Journal:

Journal of Pediatric Hematology/Oncology

Year:

2015

Language:

english

File:

PDF, 428 KB

english, 2015

42

The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma

Yamane, Brett H, Hank, Jacquelyn A, Albertini, Mark R, Sondel, Paul M

Journal:

Expert Opinion on Investigational Drugs

Year:

2009

Language:

english

File:

PDF, 708 KB

english, 2009

43

Activation of Multiple Effector Mechanisms to Enhance Tumor lmmunotherapy

Hank, Jacquelyn A., Albertini, Mark R., Schiller, Joan, Sondel, Paul M.

Journal:

Journal of Immunotherapy

Year:

1993

File:

PDF, 568 KB

1993

44

Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma

Albertini, Mark R., Ranheim, Erik A., Zuleger, Cindy L., Sondel, Paul M., Hank, Jacquelyn A., Bridges, Alan, Newton, Michael A., McFarland, Thomas, Collins, Jennifer, Clements, Erin, Henry, Mary Beth,

Journal:

Cancer Immunology, Immunotherapy

Year:

2016

Language:

english

File:

PDF, 832 KB

english, 2016

45

Ex Vivo Evaluation of Anti-EpCAM Immunocytokine huKS-IL2 in Ovarian Cancer

Connor, Joseph P., Felder, Mildred, Hank, Jacquelyn, Harter, Josephine, Gan, Jacek, Gillies, Stephen D., Sondel, Paul

Journal:

Journal of Immunotherapy

Year:

2004

Language:

english

File:

PDF, 623 KB

english, 2004

46

Prospects for Clinical Cancer Treatment Using Interleukin-2

Sondel, Paul M., Hank, Jacquelyn A.

Journal:

Cancer Investigation

Year:

1989

Language:

english

File:

PDF, 658 KB

english, 1989

47

Immunological Effects of Levamisole In Vitro

Schiller, Joan H., Lindstrom, Mary, Witt, Patricia L., Hank, Jacquelyn A., Mahvi, David, Wagner, Randall J., Sondel, Paul, Borden, Ernest C.

Journal:

Journal of Immunotherapy

Year:

1991

Language:

english

File:

PDF, 95 KB

english, 1991

48

Systemic Interleukin-2 Modulates the Anti-Idiotypic Response to Chimeric Anti-GD2 Antibody in Patients with Melanoma

Albertini, Mark R., Gan, Jacek, Jaeger, Peter, Hank, Jacquelyn A., Storer, Barry, Schell, Kathy, Rivest, Tammy, Surfus, Jean, Reisfeld, Ralph A., Schiller, Joan H., Sondel, Paul M.

Journal:

Journal of Immunotherapy

Year:

1996

File:

PDF, 1.25 MB

1996

49

Serum CD25 Levels During Interleukin-2 Therapy

Bogner, Mark P., Voss, Stephan D., Bechhofer, Robin, Hank, Jacquelyn A., Roper, Maryann, Poplack, David, Hammond, Denman, Sondel, Paul M.

Journal:

Journal of Immunotherapy

Year:

1992

File:

PDF, 703 KB

1992

50

Activation of Human T Cells Obtained Pre- and Post-Interleukin-2 (IL-2) Therapy by Anti-CD3 Monoclonal Antibody plus IL-2

Weil-Hillman, Gilda, Schell, Kathleen, Segal, David M., Hank, Jacquelyn A., Sosman, Jeffrey A., Sondel, Paul M.

Journal:

Journal of Immunotherapy

Year:

1991

File:

PDF, 934 KB

1991